Parisa Malakouti, Mobin Mohammadi, Mohammad Amin Boshagh, A. Amini, M. Rezaee, M. Rahmani
{"title":"Combined effects of pioglitazone and doxorubicin on migration and invasion of MDA-MB-231 breast cancer cells","authors":"Parisa Malakouti, Mobin Mohammadi, Mohammad Amin Boshagh, A. Amini, M. Rezaee, M. Rahmani","doi":"10.1186/s43046-022-00110-x","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":17301,"journal":{"name":"Journal of the Egyptian National Cancer Institute","volume":" ","pages":""},"PeriodicalIF":2.1000,"publicationDate":"2022-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Egyptian National Cancer Institute","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s43046-022-00110-x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
期刊介绍：
As the official publication of the National Cancer Institute, Cairo University, the Journal of the Egyptian National Cancer Institute (JENCI) is an open access peer-reviewed journal that publishes on the latest innovations in oncology and thereby, providing academics and clinicians a leading research platform. JENCI welcomes submissions pertaining to all fields of basic, applied and clinical cancer research. Main topics of interest include: local and systemic anticancer therapy (with specific interest on applied cancer research from developing countries); experimental oncology; early cancer detection; randomized trials (including negatives ones); and key emerging fields of personalized medicine, such as molecular pathology, bioinformatics, and biotechnologies.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
